Market Research Reports, Inc.

Type 1 Diabetes - Epidemiology Forecast to 2023, New Report Launched

Market Research Reports, Inc. has announced the addition of “EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023” research report to their offering.


Lewes, DE -- (SBWIRE) -- 11/03/2014 -- Type 1 diabetes, formerly referred to as insulin-dependent diabetes, is a type of diabetes that predominantly develops in children or young adults before the age of 40 years. The condition, therefore, was also referred to as juvenile diabetes. Type 1 diabetes accounts for about 10% of all diabetes cases and occurs as a result of the autoimmune destruction of pancreatic beta cells, which are responsible for producing insulin – a hormone that regulates blood sugar. If the condition is left untreated, blood sugar levels accumulate. In addition to the pancreas, high levels of blood sugar can damage other major organs, such as the heart, blood vessels, nerves, eyes, and kidneys; such damage can be life threatening. Thus, type 1 diabetes has an immense impact on the physical, psychological, and social well-being of patients. Furthermore, research suggests that the incidence of type 1 diabetes is increasing globally, which may lead to an increased burden on healthcare resources (Holt et al., 2004; Mayo Clinic, 2014; WHO, 2013).

This report provides an overview of the risk factors, comorbidities, and the global and historical trends for type 1 diabetes in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). In addition, the report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of type 1 diabetes segmented by age (ages 0–14 years,15–29 years, 30–44 years, 45–59 years, 60–74 years, and ?75 years) and sex. Furthermore, the report provides the distribution of diagnosed prevalent cases of type 1 diabetes segmented by body mass index (BMI) (kg/m2) (BMI <20, BMI 20–<25, BMI 25–<30, BMI ?30) in these markets.

According to Publisher’s analysis, the diagnosed prevalent cases of type 1 diabetes in the 8MM will grow by 40.40% over the next decade, from 6.02 million prevalent cases in 2013 to 8.45 million prevalent cases in 2023. Publisher epidemiologists attribute the increase in the diagnosed prevalent cases of type 1 diabetes in the 8MM to environmental factors (seasonal variation) coupled with genetic factors, such as a family history of type 1 diabetes. However, further research is necessary to clearly understand the epidemiological factors responsible for the growth in the prevalent cases of type 1 diabetes (Onkamo et al., 1999).

Spanning over 49 pages, “EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023” report covering the Introduction, Epidemiology, Appendix.

Know more about this report at –

Find all Pharma and Healthcare Report at:

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For regular industry updates subscribe to our newsletter at: